Leonard Baker
Developmental - Behavioral Pediatrics · la Canada, CANPI 1255453627
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $11,700 of the $16,806 with a category attached, or 69.6%. Tris Pharma Inc accounts for 73.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $5,515 and has fallen 92.1% since, to $436 in 2025. Among developmental - behavioral pediatrics clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 212 payments — averaging $79.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$12K
- Adlon Therapeutics L.p.$2K
- Supernus Pharmaceuticals, Inc.$889
- Corium, LLC$492
- Ironshore Pharmaceuticals Inc.$355
- Takeda Pharmaceuticals U.S.A., Inc.$250
- plus $490 from 6 others
What the payments were for
- Consulting fees$1,90811%
- Speaking & faculty fees$11,70070%
- Food & beverage$3,19219%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 45 | $12,290 |
| Adlon Therapeutics L.p. | 9 | $2,041 |
| Supernus Pharmaceuticals, Inc. | 69 | $889 |
| Corium, LLC | 28 | $492 |
| Ironshore Pharmaceuticals Inc. | 19 | $355 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $250 |
| Neos Therapeutics, LP | 8 | $166 |
| Vertical Pharmaceuticals, LLC | 7 | $134 |
| Collegium Pharmaceutical, Inc. | 6 | $114 |
| Shire North American Group Inc | 2 | $42 |
| Avion Pharmaceuticals | 1 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Quillichew ER$11,700
- Dyanavel XR$11,700
- Quillivant$8,400
- Quillivant XR$3,300
- ADHANSIA XR$1,908
How this compares
$16,806 in reported general payments places this provider in the 95th percentile of 52 developmental - behavioral pediatrics providers in California.
See all developmental - behavioral pediatrics providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 27 | $3,815 |
| Oxcarbazepine | 12 | $438 |
| Dexmethylphenidate Hcl | 11 | $346 |
| Escitalopram Oxalate | 21 | $325 |
| Memantine Hcl | 14 | $70 |
| Propranolol Hcl | 18 | $49 |
| Citalopram HbrCitalopram Hydrobromide | 13 | $5 |
Paid to pharmacies, not to this prescriber.
Other developmental - behavioral pediatrics in la Canada
- Ricki Robinsonla Canada$187
- Rudolf BrutocoIrvine$13K
- Mimi KimLos Angeles$12K
- Mark RuggieroTruckee$4K
- Dana WonLos Altos$3K
- Mary Jane PionkSan Jose$2K
- Anshu BatraLos Angeles$2K
- Damon KorbLos Gatos$2K
- Randi HagermanDavis$1K
- Audrey GriesbachLos Angeles$895
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.